Company Filing History:
3 out of 179 
1 out of 138 
1 out of 109 Years Active: 2014-2022
Title: Laura Griffin: Innovator in Antibody Fusion Technology
Introduction
Laura Griffin is a prominent inventor based in Slough, GB. She has made significant contributions to the field of biotechnology, particularly in the development of dual specificity antibody fusion proteins. With a total of 5 patents to her name, her work has the potential to impact various therapeutic applications.
Latest Patents
One of Laura Griffin's latest patents focuses on dual specificity antibody fusions. This invention provides dual specificity antibody fusion proteins that comprise an antibody Fab or Fab' fragment with specificity for an antigen of interest. The fragment is fused to at least one single domain antibody that has specificity for a second antigen of interest. This innovative approach enhances the efficacy of antibody-based therapies.
Career Highlights
Throughout her career, Laura has worked with notable companies such as UCB Pharma and UCB Biopharma. Her experience in these organizations has allowed her to refine her expertise in antibody technology and contribute to groundbreaking research.
Collaborations
Laura has collaborated with esteemed colleagues, including David Paul Humphreys and Emma Dave. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Laura Griffin is a trailblazer in the field of antibody fusion technology, with a strong portfolio of patents and a collaborative spirit. Her contributions continue to shape the future of biopharmaceuticals and therapeutic development.